SynVaccine Revolutionizes the Fields of Gene Therapy, Cancer Immunotherapy and Infectious Diseases using computational and wet lab viral engineering
Introducing SynRAD - a Computational Engine that Enables the
Rational Design and Construction of Viral Based Products
What can SynRAD do for you? Watch our movie above
SynVaccine specializes in viral engineering for the development of potent vaccines, viral-based gene therapy and cancer immunotherapy.
Through its proprietary platform technology, SynVaccine presents a breakthrough in the development of viral-based products – that of rational design.